189 related articles for article (PubMed ID: 9259700)
1. The economic cost of ESRD, vascular access procedures, and Medicare spending for alternative modalities of treatment. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S160-77. PubMed ID: 9259700
[No Abstract] [Full Text] [Related]
2. The economic cost of ESRD and Medicare spending for alternative modalities of treatment. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S118-31. PubMed ID: 9713414
[No Abstract] [Full Text] [Related]
3. Treatment modalities for ESRD patients. USRDS. United State Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S54-66. PubMed ID: 9259693
[No Abstract] [Full Text] [Related]
4. Annual facility survey of providers of ESRD therapy. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S178-86. PubMed ID: 9259701
[No Abstract] [Full Text] [Related]
5. Analytical methods. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S195-213. PubMed ID: 9259703
[No Abstract] [Full Text] [Related]
6. Synthetic vascular hemodialysis access versus native arteriovenous fistula: a cost-utility analysis.
Rosas SE; Feldman HI
Ann Surg; 2012 Jan; 255(1):181-6. PubMed ID: 21918428
[TBL] [Abstract][Full Text] [Related]
7. Hospitalization. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S145-59. PubMed ID: 9259699
[No Abstract] [Full Text] [Related]
8. International comparisons of ESRD therapy. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S187-94. PubMed ID: 9259702
[No Abstract] [Full Text] [Related]
9. Patient mortality and survival. USRDS. United State Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S86-106. PubMed ID: 9259695
[No Abstract] [Full Text] [Related]
10. Treatment modalities for ESRD patients. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S50-9. PubMed ID: 9713407
[No Abstract] [Full Text] [Related]
11. Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriers.
Schon D; Blume SW; Niebauer K; Hollenbeak CS; de Lissovoy G
Clin J Am Soc Nephrol; 2007 Mar; 2(2):268-76. PubMed ID: 17699424
[TBL] [Abstract][Full Text] [Related]
12. X. The economic cost of ESRD and Medicare spending for alternative modalities of treatment.
Am J Kidney Dis; 1999 Aug; 34(2 Suppl 1):S124-39. PubMed ID: 10431009
[No Abstract] [Full Text] [Related]
13. Incidence and prevalence of ESRD. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S40-53. PubMed ID: 9259692
[TBL] [Abstract][Full Text] [Related]
14. Causes of death. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S107-17. PubMed ID: 9259696
[No Abstract] [Full Text] [Related]
15. The USRDS and its products. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S21-39. PubMed ID: 9259691
[No Abstract] [Full Text] [Related]
16. The USRDS Dialysis Morbidity and Mortality Study: Wave 2. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S67-85. PubMed ID: 9259694
[No Abstract] [Full Text] [Related]
17. Annual facility survey of providers of ESRD therapy. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S132-5. PubMed ID: 9713415
[No Abstract] [Full Text] [Related]
18. Health care policies/economics of the geriatric renal population.
Eggers PW
Am J Kidney Dis; 1990 Oct; 16(4):384-91. PubMed ID: 2121023
[TBL] [Abstract][Full Text] [Related]
19. Medication use among dialysis patients in the DMMS. United States Renal Data System. Dialysis Morbidity and Mortality Study.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S60-8. PubMed ID: 9713408
[No Abstract] [Full Text] [Related]
20. Exploring kidney dialysis costs in the United States: a scoping review.
Stewart F; Kistler K; Du Y; Singh RR; Dean BB; Kong SX
J Med Econ; 2024; 27(1):618-625. PubMed ID: 38605648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
